CYTL1 and breast carcinoma: 12 In contrast to known tumor suppressors involved in regulating cancer cell metabolism, which are frequently mutated, intracellular CYTL1 acts as a novel tumor suppressor that shifts metabolic reprogramming toward OXPHOS by stabilizing a mitochondrial protein in breast cancer.